Antimicrobial resistance status and prevalence rates of extended spectrum beta-lactamase producers isolated from a mixed human population

Bosnian Journal of Basic Medical Sciences

Volumn 11, Issue 2, 2011, Pages 91-96

  Afunwa, Ruth A ^a   Odimegwu, Damian C ^a,b   Iroha, Romanus I ^c   Esimone, Charles O ^d  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c EBONYI STATE UNIVERSITY   (Nigeria)

^d NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

Author keywords

Antibiotics; Conjugation; Enterobacteriaceae; Extended spectrum beta lactamase (ESBL); Pseudomonas aeruginosa; Resistance plasmid

Indexed keywords

EID: 79958822687     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2011.2588     Document Type: Article

References (31)

1. Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Bes-bes M et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli: Study of an outbreak in an intensive care unit. Ann Intern Med 1989;110: 873-881.
2. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39 (Suppl 6):122-133.
3. Lavilla S, González-López JJ, Miró E, Domínguez A, Llagostera M, Bartolomé RM et al. Dissemination of extended-spectrum b-lacta-mase producing bacteria: the food-borne outbreak lesson. J Antimicrob Chemother 2008; 61:1244-1251.
4. Weinbren MJ, Borthwick MA. Rapid detection of extended-spectrum b-lactamase (ESBL)-producing organisms in blood culture. J Antimicrob Chemother 2005; 55:131-132.
5. Nordmann P, Naas T. Sequence analysis of PER-i extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases. Antimicrob Agents Chemother 1994;38:104-114.
6. Borer A, Gilad J, Menashe G, Peled N, Riesenberg K, Schlaeffer F. Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in southern Israel. Med Sci Monit 2002; 8:44-47.
7. Canton R, Coque TM. T e CTX-M b-lactamase pandemic. Curr Opin Microbiol 2006; 9:466-475.
8. Paterson DL. Resistance in Gram-negative bacteria: Enterobacteriaceae. Am J Med 2006; 119: S20-S28.
9. Pena C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum blactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 1997; 35:9-16.
10. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of En-terobacteriaceae producing extended-spectrum blactamases (ES-BLs) in the community. J Antimicrob Chemother 2005; 56: 52-59.
11. Ramphal R, Ambrose PG. Extended-spectrum blactamases and clinical outcomes: current data. Clin Infect Dis 2006; 42: S164-S172.
12. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162-1171.
13. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum be-talactamases. Clin Infect Dis 2004; 39: 31-37.
14. Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intraabdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006; 58: 205-210.
15. National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-485.
16. Iroha IR, Amadi ES, Adikwu MU, Esimone CO. Detection of plas-mid borne Extended Spectrum Beta Lactamase enzymes in clinical isolates of Escherichia coli from a community general hospital. Int J Med Adv in press.
17. Albinu I, Odugbemi P, Brian JM. Extended spectrum beta lactamases in isolates of Klebsiella species and Escherichia coli from Lagos, Nigeria. Nig J Health and Biomed Science 2003; 2 (Suppl 2): 53-60.
18. Iroha IR, Oji AE, Esimone CO. Antimicrobial resistance pattern of plasmid mediated extended spectrum beta-lactamase producing strain of Escherichia coli. Sci Res Essay 2008, 3 (Suppl 6): 215-218.
19. st edition. Enugu: Demak Publishers; 2005, pp. 61-64.
20. Gutmann L, Williamson R, Moreau R, Kitzis MD, Collatz E, Acar JF et al. Cross resistance to nalidixic acid, trimethoprim and chloramphenicol associated with alterations in the outer membrane proteins of Klebsiella, Enterobacter and Serratia. J Infect Dis 1985; 151: 501-507.
21. Cohen ML, Auxe RV. Drug resistant Salmonella in the United States: an epidemiologic perspective. Science 1992; 234:964-970.
22. Sheikh AR, Afsheen A, Sadia K, Abdul W. Plasmid borne antibiotic resistance factors among indigenous Klebsiella. Pak J Bot 2003; 35 (Suppl 2): 243-248.
23. Begue P. Current orientation of antibiotic treatment in neonatal bacterial infection. Bull Soc Pathol Exot 1991; 84: 712-720.
24. Hansotia JB, Agarwal V, Pathak AA, Saoji AM. Extended spectrum b-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res 1997; 105:158-161.
25. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC et al. Risk Factors for Colonization with Extended-Spectrum β-Lactamase-Producing Bacteria and Intensive Care Unit Admission. Emerg Infect Dis 2007; 13 (Suppl 8): 1144-1149.
26. Amita J, Indranil R, Mahendra KG, Mala K, Agarwal SK. Prevalence of extended-spectrum-lactamaseproducing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 2003; 52:421-425.
27. Esimone CO, Nworu CS, Udeogaranya OP. Utilization of antimicrobial agents with and without prescription by outpatients in selected pharmacies in South- Eastern Nigeria. Pharm Sci Journal 2007; 11096 p 6.
28. Olowe OA, Aboderin BW. Detection of extended spectrum ß-lactamase producing strains of Escherichia coli and Klebsiella sp in a tertiary Health centre in Ogun State. Int J of Trop Med 2010; 5 (3): 62-64.
29. Afiukwa F.N., Iroha I.R., Afiukwa C.A., Ayogu T.E., Oji A.E., Onwa N.C., (2010). Presence of coliform producing extended spectrum beta lactamase in sachet-water manufactured and sold in Abakaliki, Ebonyi State, Nigeria. Int Res J Microb 2010; 1 (2): 32-36.
30. Enabulele OI, Aluyi HAS, Omokao O: Incidence of bacteraemia following teeth extraction at the dental clinic of the University of Benin Teaching Hospital, Benin City, Nigeria. Afr J Biotechnol 2008; 7 (Suppl 10): 1390-1393.
31. Yah, SC, Eghaforia NO, Oranusi S, Abono AM: Widespread plasmid resistance genes among Proteus species in diabetic wounds of patients in the Ahmadu Bello University Teaching Hospital (ABUTH) Zaria. Afr J Biotechnol 2007; 6 (Suppl 15): 1757-1762.